PeerCurrent.com|Stay current with the people and research shaping what comes next.

About Privacy Terms Support

PeerCurrent

PcPeerCurrent

Your Feed AI Summary Saved Board Expert Discussion This Week in Your Field

Follows Journals Trials Guidelines Markets

Set your cadence Alerts Settings Help

Back to follows

Researcher

Meili Pei

First Affiliated Hospital of Xi'an Jiaotong University

1 development in the corpus

Following this puts new work involving it at the top of your briefing, with a note saying why it is there. Links are taken from the source record, never inferred.

For You Latest Breakthroughs Trials Reviews Guidelines

Latest

Everything in the corpus, newest first.

SEP 4, 2026 · JOURNAL ARTICLE

A Locally Injectable, pH/ROS-Responsive Hydrogel Platform for Combination Therapy of Cervical Cancer with Anti-Fibrotic and Chemotherapeutic Agents

Pharmaceutics

Early-stage preclinical work demonstrating proof-of-concept in cell culture and mouse models; no clinical efficacy data, human trials, or comparison to standard cervical cancer therapy reported.

PreliminaryMeili Pei Yubei Li Hui Yang

Study details

DesignPreclinical in vitro and in vivo mouse mode…

InterventionLocally injectable pH/ROS-responsive hydrog…

PeerCurrent.com|Stay current with the people and research shaping what comes next.

About Privacy Terms Support